Global Cell and Gene Therapy Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Cell and Gene Therapy
    1.2 Classification of Cell and Gene Therapy by Type
        1.2.1 Overview: Global Cell and Gene Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Cell and Gene Therapy Revenue Market Share by Type in 2020
        1.2.3 Rare Diseases
        1.2.4 Oncology
        1.2.5 Hematology
        1.2.6 Cardiovascular
        1.2.7 Ophthalmology
        1.2.8 Neurology
        1.2.9 Other Therapeutic Classes
    1.3 Global Cell and Gene Therapy Market by Application
        1.3.1 Overview: Global Cell and Gene Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Pharmaceutical and Biotechnology Companies
        1.3.3 Research and Academic Institutions
        1.3.4 Contract Research Organizations (CROs)
        1.3.5 Hospital
        1.3.6 Others
    1.4 Global Cell and Gene Therapy Market Size & Forecast
    1.5 Global Cell and Gene Therapy Market Size and Forecast by Region
        1.5.1 Global Cell and Gene Therapy Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Cell and Gene Therapy Market Size by Region, (2016-2021)
        1.5.3 North America Cell and Gene Therapy Market Size and Prospect (2016-2026)
        1.5.4 Europe Cell and Gene Therapy Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Cell and Gene Therapy Market Size and Prospect (2016-2026)
        1.5.6 South America Cell and Gene Therapy Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Cell and Gene Therapy Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Cell and Gene Therapy Market Drivers
        1.6.2 Cell and Gene Therapy Market Restraints
        1.6.3 Cell and Gene Therapy Trends Analysis
2 Company Profiles
    2.1 Amgen Inc.
        2.1.1 Amgen Inc. Details
        2.1.2 Amgen Inc. Major Business
        2.1.3 Amgen Inc. Cell and Gene Therapy Product and Solutions
        2.1.4 Amgen Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Amgen Inc. Recent Developments and Future Plans
    2.2 bluebird bio, Inc.
        2.2.1 bluebird bio, Inc. Details
        2.2.2 bluebird bio, Inc. Major Business
        2.2.3 bluebird bio, Inc. Cell and Gene Therapy Product and Solutions
        2.2.4 bluebird bio, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 bluebird bio, Inc. Recent Developments and Future Plans
    2.3 Dendreon Pharmaceuticals LLC.
        2.3.1 Dendreon Pharmaceuticals LLC. Details
        2.3.2 Dendreon Pharmaceuticals LLC. Major Business
        2.3.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product and Solutions
        2.3.4 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Dendreon Pharmaceuticals LLC. Recent Developments and Future Plans
    2.4 Fibrocell Science, Inc.
        2.4.1 Fibrocell Science, Inc. Details
        2.4.2 Fibrocell Science, Inc. Major Business
        2.4.3 Fibrocell Science, Inc. Cell and Gene Therapy Product and Solutions
        2.4.4 Fibrocell Science, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Fibrocell Science, Inc. Recent Developments and Future Plans
    2.5 Human Stem Cells Institute
        2.5.1 Human Stem Cells Institute Details
        2.5.2 Human Stem Cells Institute Major Business
        2.5.3 Human Stem Cells Institute Cell and Gene Therapy Product and Solutions
        2.5.4 Human Stem Cells Institute Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Human Stem Cells Institute Recent Developments and Future Plans
    2.6 Kite Pharma, Inc.
        2.6.1 Kite Pharma, Inc. Details
        2.6.2 Kite Pharma, Inc. Major Business
        2.6.3 Kite Pharma, Inc. Cell and Gene Therapy Product and Solutions
        2.6.4 Kite Pharma, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Kite Pharma, Inc. Recent Developments and Future Plans
    2.7 Kolon TissueGene, Inc.
        2.7.1 Kolon TissueGene, Inc. Details
        2.7.2 Kolon TissueGene, Inc. Major Business
        2.7.3 Kolon TissueGene, Inc. Cell and Gene Therapy Product and Solutions
        2.7.4 Kolon TissueGene, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Kolon TissueGene, Inc. Recent Developments and Future Plans
    2.8 Novartis AG
        2.8.1 Novartis AG Details
        2.8.2 Novartis AG Major Business
        2.8.3 Novartis AG Cell and Gene Therapy Product and Solutions
        2.8.4 Novartis AG Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Novartis AG Recent Developments and Future Plans
    2.9 Orchard Therapeutics plc.
        2.9.1 Orchard Therapeutics plc. Details
        2.9.2 Orchard Therapeutics plc. Major Business
        2.9.3 Orchard Therapeutics plc. Cell and Gene Therapy Product and Solutions
        2.9.4 Orchard Therapeutics plc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Orchard Therapeutics plc. Recent Developments and Future Plans
    2.10 Organogenesis Holdings Inc. 
        2.10.1 Organogenesis Holdings Inc. Details
        2.10.2 Organogenesis Holdings Inc. Major Business
        2.10.3 Organogenesis Holdings Inc. Cell and Gene Therapy Product and Solutions
        2.10.4 Organogenesis Holdings Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Organogenesis Holdings Inc. Recent Developments and Future Plans
    2.11 Pfizer, Inc.
        2.11.1 Pfizer, Inc. Details
        2.11.2 Pfizer, Inc. Major Business
        2.11.3 Pfizer, Inc. Cell and Gene Therapy Product and Solutions
        2.11.4 Pfizer, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 Pfizer, Inc. Recent Developments and Future Plans
    2.12 RENOVA THERAPEUTICS
        2.12.1 RENOVA THERAPEUTICS Details
        2.12.2 RENOVA THERAPEUTICS Major Business
        2.12.3 RENOVA THERAPEUTICS Cell and Gene Therapy Product and Solutions
        2.12.4 RENOVA THERAPEUTICS Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 RENOVA THERAPEUTICS Recent Developments and Future Plans
    2.13 Shanghai Sunway Biotech Co., Ltd.,
        2.13.1 Shanghai Sunway Biotech Co., Ltd., Details
        2.13.2 Shanghai Sunway Biotech Co., Ltd., Major Business
        2.13.3 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Product and Solutions
        2.13.4 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Shanghai Sunway Biotech Co., Ltd., Recent Developments and Future Plans
    2.14 Sibiono GeneTech Co. Ltd.,
        2.14.1 Sibiono GeneTech Co. Ltd., Details
        2.14.2 Sibiono GeneTech Co. Ltd., Major Business
        2.14.3 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Product and Solutions
        2.14.4 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Sibiono GeneTech Co. Ltd., Recent Developments and Future Plans
    2.15 Spark Therapeutics, Inc.
        2.15.1 Spark Therapeutics, Inc. Details
        2.15.2 Spark Therapeutics, Inc. Major Business
        2.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Product and Solutions
        2.15.4 Spark Therapeutics, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.15.5 Spark Therapeutics, Inc. Recent Developments and Future Plans
    2.16 Vericel Corporation
        2.16.1 Vericel Corporation Details
        2.16.2 Vericel Corporation Major Business
        2.16.3 Vericel Corporation Cell and Gene Therapy Product and Solutions
        2.16.4 Vericel Corporation Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.16.5 Vericel Corporation Recent Developments and Future Plans
    2.17 ViroMed Co., Ltd.
        2.17.1 ViroMed Co., Ltd. Details
        2.17.2 ViroMed Co., Ltd. Major Business
        2.17.3 ViroMed Co., Ltd. Cell and Gene Therapy Product and Solutions
        2.17.4 ViroMed Co., Ltd. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
        2.17.5 ViroMed Co., Ltd. Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Cell and Gene Therapy Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Cell and Gene Therapy Players Market Share
        3.2.2 Top 10 Cell and Gene Therapy Players Market Share
        3.2.3 Market Competition Trend
    3.3 Cell and Gene Therapy Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Cell and Gene Therapy Revenue and Market Share by Type (2016-2021)
    4.2 Global Cell and Gene Therapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Cell and Gene Therapy Revenue Market Share by Application (2016-2021)
    5.2 Cell and Gene Therapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Cell and Gene Therapy Revenue by Type (2016-2026)
    6.2 North America Cell and Gene Therapy Revenue by Application (2016-2026)
    6.3 North America Cell and Gene Therapy Market Size by Country
        6.3.1 North America Cell and Gene Therapy Revenue by Country (2016-2026)
        6.3.2 United States Cell and Gene Therapy Market Size and Forecast (2016-2026)
        6.3.3 Canada Cell and Gene Therapy Market Size and Forecast (2016-2026)
        6.3.4 Mexico Cell and Gene Therapy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Cell and Gene Therapy Revenue by Type (2016-2026)
    7.2 Europe Cell and Gene Therapy Revenue by Application (2016-2026)
    7.3 Europe Cell and Gene Therapy Market Size by Country
        7.3.1 Europe Cell and Gene Therapy Revenue by Country (2016-2026)
        7.3.2 Germany Cell and Gene Therapy Market Size and Forecast (2016-2026)
        7.3.3 France Cell and Gene Therapy Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Cell and Gene Therapy Market Size and Forecast (2016-2026)
        7.3.5 Russia Cell and Gene Therapy Market Size and Forecast (2016-2026)
        7.3.6 Italy Cell and Gene Therapy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Cell and Gene Therapy Revenue by Type (2016-2026)
    8.2 Asia-Pacific Cell and Gene Therapy Revenue by Application (2016-2026)
    8.3 Asia-Pacific Cell and Gene Therapy Market Size by Region
        8.3.1 Asia-Pacific Cell and Gene Therapy Revenue by Region (2016-2026)
        8.3.2 China Cell and Gene Therapy Market Size and Forecast (2016-2026)
        8.3.3 Japan Cell and Gene Therapy Market Size and Forecast (2016-2026)
        8.3.4 South Korea Cell and Gene Therapy Market Size and Forecast (2016-2026)
        8.3.5 India Cell and Gene Therapy Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Cell and Gene Therapy Market Size and Forecast (2016-2026)
        8.3.7 Australia Cell and Gene Therapy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Cell and Gene Therapy Revenue by Type (2016-2026)
    9.2 South America Cell and Gene Therapy Revenue by Application (2016-2026)
    9.3 South America Cell and Gene Therapy Market Size by Country
        9.3.1 South America Cell and Gene Therapy Revenue by Country (2016-2026)
        9.3.2 Brazil Cell and Gene Therapy Market Size and Forecast (2016-2026)
        9.3.3 Argentina Cell and Gene Therapy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Cell and Gene Therapy Revenue by Type (2016-2026)
    10.2 Middle East & Africa Cell and Gene Therapy Revenue by Application (2016-2026)
    10.3 Middle East & Africa Cell and Gene Therapy Market Size by Country
        10.3.1 Middle East & Africa Cell and Gene Therapy Revenue by Country (2016-2026)
        10.3.2 Turkey Cell and Gene Therapy Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Cell and Gene Therapy Market Size and Forecast (2016-2026)
        10.3.4 UAE Cell and Gene Therapy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer